Cargando…

The Specific Mechanism of TREM2 Regulation of Synaptic Clearance in Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disease. Synaptic dysfunction is an integral feature of AD pathophysiology and a significant factor in early cognitive impairment in AD. Microglia, which are intrinsic immune cells in the central nervous system, play important regulatory ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Qi, Wang, Meng, Yin, Yunsi, Tang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160359/ https://www.ncbi.nlm.nih.gov/pubmed/35663962 http://dx.doi.org/10.3389/fimmu.2022.845897

Ejemplares similares

Microglia Mediate Synaptic Material Clearance at the Early Stage of Rats With Retinitis Pigmentosa
por: He, Juncai, et al.
Publicado: (2019)

TREM2 regulates innate immunity in Alzheimer’s disease
por: Li, Jiang-Tao, et al.
Publicado: (2018)

Targeting TREM2 for Parkinson’s Disease: Where to Go?
por: Li, Xiao-xian, et al.
Publicado: (2021)

Gene mutations associated with early onset familial Alzheimer’s disease in China: An overview and current status
por: Qin, Qi, et al.
Publicado: (2020)

TREM-1 Modulation Strategies for Sepsis
por: Siskind, Sara, et al.
Publicado: (2022)

APOE and TREM2 regulate amyloid responsive microglia in Alzheimer’s disease
por: Nguyen, Aivi T., et al.
Publicado: (2020)

Alzheimer’s Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia
por: Reich, Marvin, et al.
Publicado: (2021)

TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance
por: Xiang, Xianyuan, et al.
Publicado: (2016)

TREM2 ectodomain and its soluble form in Alzheimer’s disease
por: Yang, Jiaolong, et al.
Publicado: (2020)

Epigenetic regulation of synaptic disorder in Alzheimer’s disease
por: Chen, Zhiying, et al.
Publicado: (2022)

Soluble TREM2 is a potential biomarker for the severity of primary angiitis of the CNS
por: Guo, Tianshu, et al.
Publicado: (2022)

TREM2-Dependent Effects on Microglia in Alzheimer’s Disease
por: Zhou, Yingyue, et al.
Publicado: (2018)

New insights into the role of TREM2 in Alzheimer’s disease
por: Gratuze, Maud, et al.
Publicado: (2018)

Plasmonic Interferometers as TREM2 Sensors for Alzheimer’s Disease
por: Li, Dingdong, et al.
Publicado: (2021)

TREM2 as an evolving therapeutic target in Alzheimer’s disease
por: George, Jacob
Publicado: (2023)

Function of TREM1 and TREM2 in Liver-Related Diseases
por: Sun, Huifang, et al.
Publicado: (2020)

Association of rs2062323 in the TREM1 gene with Alzheimer's disease and cerebrospinal fluid‐soluble TREM2
por: Wang, Zuo‐Teng, et al.
Publicado: (2023)

TREM2 deficiency eliminates TREM2(+) inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
por: Jay, Taylor R., et al.
Publicado: (2015)

TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target
por: Li, Rui-Yang, et al.
Publicado: (2022)

TREM2‐induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology
por: Fracassi, Anna, et al.
Publicado: (2022)

TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy
por: Qiu, Hui, et al.
Publicado: (2021)

TREM2 is associated with tumor immunity and implies poor prognosis in glioma
por: Yu, Mingchen, et al.
Publicado: (2023)

14-3-3 [Formula: see text] -reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2
por: Woo, Marcel S., et al.
Publicado: (2023)

Microglia TREM2: A Potential Role in the Mechanism of Action of Electroacupuncture in an Alzheimer's Disease Animal Model
por: Li, Yujie, et al.
Publicado: (2020)

TREM-1 Deficiency Can Attenuate Disease Severity without Affecting Pathogen Clearance
por: Weber, Benjamin, et al.
Publicado: (2014)

Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease
por: Golde, Todd E, et al.
Publicado: (2013)

The Role of TREM2 in Alzheimer’s Disease and Other Neurological Disorders
por: Yaghmoor, Faris, et al.
Publicado: (2014)

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
por: Henjum, Kristi, et al.
Publicado: (2016)

TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
por: Zheng, Honghua, et al.
Publicado: (2018)

Reduced TREM2 activation in microglia of patients with Alzheimer's disease
por: Okuzono, Yuumi, et al.
Publicado: (2021)

Does Soluble TREM2 Protect Against Alzheimer's Disease?
por: Brown, Guy C., et al.
Publicado: (2022)

TREM2 dependent and independent functions of microglia in Alzheimer’s disease
por: Hou, Jinchao, et al.
Publicado: (2022)

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2023)

The role of TREM2 in Alzheimer’s disease: from the perspective of Tau
por: Huang, Wendi, et al.
Publicado: (2023)

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
por: Cheng, Xin, et al.
Publicado: (2021)

Integrated Analysis Highlights the Immunosuppressive Role of TREM2(+) Macrophages in Hepatocellular Carcinoma
por: Zhou, Lisha, et al.
Publicado: (2022)

BRI2-mediated regulation of TREM2 processing in microglia and its potential implications for Alzheimer’s disease and related dementias
por: Yin, Tao, et al.
Publicado: (2023)

Radiation upregulates macrophage TREM-1 expression to exacerbate injury in mice
por: Yamaga, Satoshi, et al.
Publicado: (2023)

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
por: Del-Aguila, Jorge L., et al.
Publicado: (2019)

Evidence of Trem2 Variant Associated with Triple Risk of Alzheimer’s Disease
por: Abduljaleel, Zainularifeen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ksjapa8pgb403pqelctvfdns6c